Posted by Michael Wonder on 16 Mar 2022
Pfizer and BioNTech submit for U.S. emergency use authorisation of an additional booster dose of their COVID-19 vaccine for older adults
15 March 2022 - Submission based on real-world safety and efficacy data from Israel.
Pfizer and BioNTech today announced the companies have submitted an application to the U.S. FDA for emergency use authorisation of an additional booster dose for adults 65 years of age and older who have received an initial booster of any of the authorised or approved COVID-19 vaccines.
